Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Joemare


T.TH

RE:RE:RE:RE:RE:RE:RE:RE:Finally listened to call

You write "Patient accrual is a problem".  Do you have any...

October 14, 2022

T.TH

RE:RE:RE:RE:RE:RE:Finally listened to call

Paperwork is an issue to conduct clinical trials in Canada??  Come on!!!...

October 14, 2022

T.TH

RE:RE:RE:RE:Finally listened to call

When you add countries, it means there's an issue with patient accrual...

October 14, 2022

T.TH

RE:RE:Expectations too high. Reset your animus.

Pathetic.  Either lack of competency or leadership or both.  Now...

October 13, 2022

T.TH

Executive fail. Execution failure. Delays and excuses

This was a somewhat embarassing call.

October 13, 2022

T.TH

Delays and excuses. Here we go......

In an effort to optimize and ensure success of this clinical research program...

October 13, 2022

T.TH

RE:RE:RE:News Out đź‘€

Unfortunately, nothing much here.  So, no clinical data prior to...

October 12, 2022

T.TH

RE:RE:RE:“Low dose docetaxel”

Agree with unceertainty.  Ideally, a PII comparing newly diagnosed...

October 11, 2022

T.TH

RE:This week

If no PR before Thursday, I think it will be all about delays and excuses...

October 11, 2022

T.TH

RE:RE:Meanwhile AKRO.....a 2B$ company

We shall forgive them for NASH should TH1902 lead to much better times...

October 7, 2022

T.TH

Meanwhile AKRO.....a 2B$ company

And that's how it's done. Waisted three years on NASH.....no results....

October 7, 2022

T.TH

RE:RE:RE:RE:RE:RE:Share Price Appreciation Expectations?

Stable disease = oct 13th discussion. Will not move share price 30% Response...

October 7, 2022

T.TH

RE:Share Price Appreciation Expectations?

If no PR before Oct 13, I think the stock will get further punished, or...

October 6, 2022

T.TH

RE:RE:RE:RE:Global Manager Regulatory Affairs, Oncology

If it's material, why not release a PR!  What's the problem????&...

October 6, 2022

T.TH

RE:RE:Thursday 10/13

Yup. Will not be material if they wait for the 13th. They have to release the...

October 4, 2022

T.TH

RE:RE:We need something of material value on TH1902

The point being to conduct the P1 study in Canadian hospitals...their...

October 4, 2022

T.TH

We need something of material value on TH1902

Share price will further be punished if nothing comes out before the business...

October 4, 2022

T.TH

RE:RE:RE:Trogarzo 30 sec i.v. push over two weeks

A phase-3 study for i.m. injection was initiated in 2021. Likely another two...

October 3, 2022

T.TH

Trogarzo 30 sec i.v. push over two weeks

At least, this news will make the reps happy and further motivated as they...

October 3, 2022

T.TH

What would significantly drive the share price upwards?

In my opinion, it's a punchy PR before the corporate update. ...

October 3, 2022

Prev 1 2 3 4 5 6 7 8 Next

Featured Company